Litigation Details for SENJU PHARMACEUTICAL CO., LTD. v. WATSON LABORATORIES, INC. (D.N.J. 2016)
✉ Email this page to a colleague
SENJU PHARMACEUTICAL CO., LTD. v. WATSON LABORATORIES, INC. (D.N.J. 2016)
| Docket | ⤷ Sign Up | Date Filed | 2016-03-18 |
| Court | District Court, D. New Jersey | Date Terminated | 2017-01-30 |
| Cause | 35:271 Patent Infringement | Assigned To | Jerome B. Simandle |
| Jury Demand | None | Referred To | Karen M. Williams |
| Patents | 9,144,609 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in SENJU PHARMACEUTICAL CO., LTD. v. WATSON LABORATORIES, INC.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for SENJU PHARMACEUTICAL CO., LTD. v. WATSON LABORATORIES, INC. (D.N.J. 2016)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2016-07-05 | 10 | United States Patent No. 9,144,609 (“the ʼ609 patent”), arising under the United States patent laws, Title…alleged infringement of United States Patent No. 9,144,609 (“the ’609 patent”). Defendants admit that Watson…construed claim of United States Patent No. 9,144,609 (“the ’609 patent”) either directly, indirectly,…or more claims of United States Patent No. 9,144,609 (“the ’609 patent”). … States Patent and Trademark Office of the patent applications leading to the ’609 patent, Plaintiffs | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
